SGLT2is Beyond Diabetes: A Team Effort in CVD and Renal Disease SGLT2is Beyond Diabetes: A Team Effort in CVD and Renal Disease

As use of SGLT2 inhibitors expands, treatment of patients with diabetes, heart failure, and cardiovascular and renal disease requires close collaboration among specialists and primary care providers.American College of Cardiology & Medscape

Source: Medscape Cardiology Headlines - July 16, 2020 Category: Cardiology Tags: Cardiology Commentary Source Type: news